Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000928464-13-000132
Filing Date
2013-06-11
Accepted
2013-06-11 16:02:31
Documents
4

Document Format Files

Seq Description Document Type Size
1 frxsch13damd19061013.htm SC 13D/A 182959
2 NOMINATION AND STANDSTILL AGREEMENT BETWEEN THE REPORTING PERSONS AND THE ISSUER frxsch13damd19061013ex1.htm EX-1 128684
3 CONFIDENTIALITY AGREEMENT BETWEEN THE REPORTING PERSONS AND THE ISSUER frxsch13damd19061013ex2.htm EX-2 74178
4 JOINT PRESS RELEASE ISSUED BY THE REPORTING PERSONS AND THE ISSUER frxsch13damd19061013ex3.htm EX-3 15252
  Complete submission text file 0000928464-13-000132.txt   402748
Mailing Address 909 THIRD AVENUE NEW YORK NY 10022
Business Address 909 THIRD AVENUE NEW YORK NY 10022 (212)421-7850
FOREST LABORATORIES INC (Subject) CIK: 0000038074 (see all company filings)

EIN.: 111798614 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13D/A | Act: 34 | File No.: 005-30414 | Film No.: 13906129
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ICAHN ASSOCIATES HOLDING LLC 767 FIFTH AVE., SUITE 4700 NEW YORK NY 10153
Business Address C/O ICAHN ASSOCIATES HOLDING LLC 767 FIFTH AVE., SUITE 4700 NEW YORK NY 10153 212-702-4300
ICAHN CARL C (Filed by) CIK: 0000921669 (see all company filings)

EIN.: 000000000 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 0000